Pangali Sanam, the Chief Legal Officer of Alumis Inc., has reported the sale of 332 shares of the company's common stock. This transaction, which took place on November 2, 2026, was executed as part of a policy requiring sell-to-cover to satisfy tax obligations incurred from the vesting of restricted stock units granted on July 29, 2025. This sale does not represent a discretionary action by Sanam.

The sale was completed at a weighted average price of $6.52 per share, with individual transaction prices ranging from $6.41 to $6.52. Following this transaction, Sanam retains ownership of 9,415 shares in Alumis Inc.

Background

Alumis Inc. operates within the pharmaceutical preparations industry, classified under Standard Industrial Classification 2834. The company is based in South San Francisco, California, and has undergone name changes in recent years. The most recent filing for Alumis was on November 4, 2026, as a Form 4, reporting ownership changes.

What the Filing Says

According to the SEC filing (accession number 0002023806-26-000009), the reported transaction was necessary for Sanam to meet tax obligations associated with previously granted stock units. The filing states, "The sale reported on this Form 4 was effected pursuant to the Issuer's policy requiring sell-to-cover to satisfy tax obligations of the Reporting Person." This emphasizes the importance of tax management in the context of stock compensation.

Impact

This transaction may affect Alumis Inc.'s shareholders and stakeholders by providing insight into the company's financial management and the personal financial decisions of its executives. The pharmaceutical preparations sector, where Alumis operates, remains competitive, and such transactions can indicate the financial health and strategic planning of its leaders.

What's Next

The filing does not say what happens next.